The graphic below is the second in a two part series that explores how psychedelics have evolved over the last 6,000 years. In part one of this two-part series, we unearthed the story behind the prohibition of psychedelic substances, and how strict regulations resulted in a hugely stigmatized industry.
After decades of being labeled as illegal narcotics, the industry reinvented itself as a viable solution for treating hard-to-treat illnesses in a safe and controlled way. This unprecedented comeback has sparked a global medicinal psychedelics movement, with the U.S. leading the way in decriminalizing these powerful drugs.
The following content is sponsored by Tryp Therapeutics.
Editor’s Note: The original post has been edited ([ ]) and abridged (…) above for the sake of clarity and brevity to ensure a fast and easy read. The author’s views and conclusions are unaltered and no personal comments have been included to maintain the integrity of the original article. Furthermore, the views, conclusions and any recommendations offered in this article are not to be construed as an endorsement of such by the editor. Also note that this complete paragraph must be included in any re-posting to avoid copyright infringement.
Related Articles from the munKNEE Vault
Which index out-performed in September, the munKNEE Pure-Play Marijuana-Based Drug Stocks Index or the munKNEE Pure-Play Psychedelic Compounds-Based Drug Stocks Index.? This article has the answer.
AdvisorShares Psychedelics ETF (Ticker: PSIL) began trading on the NYSE Acra exchange on Thursday, September 16th as the first U.S.-listed actively managed ETF to deliver dedicated investment exposure to psychedelics. All 5 are compared to help you decide which ETF to invest in or which ETF or Index to follow for the latest activity in the fledgling sector.
There are almost 100 relatively new sites available that cover various aspects of the fledgling but burgeoning cannabis and psychedelic markets but only 28 provide information of interest to current or potential investors.
This article identifies the 10 psychedelic substances undergoing extensive research, those with the most therapeutic and commercial potential and the companies that are most involved in such research to help you decide which offer the best investment opportunities.
Curious about the purported beneficial effects of psilocybin mushrooms on the mind, the writer decided to attend a guided hallucinogenic trip and found it to be the most important experience of his life.
The supposedly first and, supposedly, a “psychedelic” stocks ETF, was launched in the U.S. on May 27th. but it is not a true psychedelic stocks ETF nor is it the world’s first psychedelic ETF. This article uncovers what it really is.
The graphic below…provides a visual overview of the major sectors that make up the multi-billion dollar psychedelics industry, as well as some of the most active companies that operate within each of them.
This infographic is the first in a two-part series that explores how psychedelics have evolved over the last 6,000 years.
A Few Last Words:
- Click the “Like” button at the top of the page if you found this article a worthwhile read as this will help us build a bigger audience.
- Comment below if you want to share your opinion or perspective with other readers and possibly exchange views with them.
- Register to receive our free Market Intelligence Report newsletter (sample here) in the top right hand corner of this page.
- Join us on Facebook to be automatically advised of the latest articles posted and to comment on any of them.